Parnetti L - Search Results

1

Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease.

Barba L, Halbgebauer S, Paolini Paoletti F, Bellomo G, Abu-Rumeileh S, Steinacker P, Massa F, Parnetti L, Otto M. Barba L, et al. Among authors: parnetti l. Int J Mol Sci. 2022 Jun 22;23(13):6922. doi: 10.3390/ijms23136922. Int J Mol Sci. 2022. PMID: 35805926 Free PMC article.

2

Blood pressure and functional aspects of the aging brain.

Parnetti L, Mecocci P, Ciuffetti G, Bellomo G, Senin U. Parnetti L, et al. Arch Gerontol Geriatr. 1989 Sep-Oct;9(2):155-61. doi: 10.1016/0167-4943(89)90036-8. Arch Gerontol Geriatr. 1989. PMID: 2589916

3

Meal-induced arterial blood pressure variations in the elderly.

Bellomo G, Santucci S, Aisa G, Parnetti L. Bellomo G, et al. Among authors: parnetti l. Gerontology. 1988;34(5-6):311-4. doi: 10.1159/000212972. Gerontology. 1988. PMID: 3220266

4

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F; Phospho-Tau International Study Group. Parnetti L, et al. Neurol Sci. 2001 Feb;22(1):77-8. doi: 10.1007/s100720170055. Neurol Sci. 2001. PMID: 11487210

5

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

Parnetti L, Amici S, Lanari A, Romani C, Antognelli C, Andreasen N, Minthon L, Davidsson P, Pottel H, Blennow K, Gallai V. Parnetti L, et al. Neurol Sci. 2002 Sep;23 Suppl 2:S95-6. doi: 10.1007/s100720200086. Neurol Sci. 2002. PMID: 12548360 Clinical Trial.

6

Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice.

Parnetti L, Lanari A, Saggese E, Spaccatini C, Gallai V. Parnetti L, et al. Neurol Sci. 2003 Oct;24(3):199-200. doi: 10.1007/s10072-003-0129-8. Neurol Sci. 2003. PMID: 14598086

7

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.

Parnetti L, Lanari A, Silvestrelli G, Saggese E, Reboldi P. Parnetti L, et al. Mech Ageing Dev. 2006 Feb;127(2):129-32. doi: 10.1016/j.mad.2005.09.022. Epub 2005 Nov 7. Mech Ageing Dev. 2006. PMID: 16274728

8

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P. Parnetti L, et al. Biol Psychiatry. 2008 Nov 15;64(10):850-5. doi: 10.1016/j.biopsych.2008.02.016. Epub 2008 Apr 8. Biol Psychiatry. 2008. PMID: 18395699

9

Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?

Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L. Palumbo B, et al. Among authors: parnetti l. Funct Neurol. 2008 Apr-Jun;23(2):93-6. Funct Neurol. 2008. PMID: 18671910

10

Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies.

Parnetti L, Balducci C, Pierguidi L, De Carlo C, Peducci M, D'Amore C, Padiglioni C, Mastrocola S, Persichetti E, Paciotti S, Bellomo G, Tambasco N, Rossi A, Beccari T, Calabresi P. Parnetti L, et al. Neurobiol Dis. 2009 Jun;34(3):484-6. doi: 10.1016/j.nbd.2009.03.002. Epub 2009 Mar 20. Neurobiol Dis. 2009. PMID: 19303930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters